BiocommAI will leverage VAST Data Platform and BiocommAI’s BIOTHRIVOLOGY™ technology to Pioneer Next-Generation Infrastructure for trustworthy contained and controlled Safe Artificial Intelligence (“Safe AI”) with initial focus on Regulatory Compliant Innovations in Health and Life Sciences for People Living with Cancer

San Jose, California – March 20, 2025 – BiocommAI Inc., a member of NVIDIA Inception and NIST AISIC and IASEAI are pioneering inherently Safe AI technologies in cooperation with VAST Data Inc., the AI data platform company and a Certified Solution Fully Integrated with the NVIDIA Ecosystem, today announced a strategic partnership to develop and deliver next-generation data platforms architected with Safe AI for ethical, and high-performance Artificial Intelligence. This collaboration combines the power of the VAST Data Platform with BiocommAI’s groundbreaking BIOTHRIVOLOGY™ framework to address the critical need for trustworthy and responsible AI infrastructure as the industry rapidly advances.

As AI adoption accelerates across industries, ensuring the Safe AI and ethical operation of AI systems is paramount. This partnership directly tackles this challenge by integrating BiocommAI’s BIOTHRIVOLOGY™, a novel approach to AI system design focused on containment and control, from the ground up, with the VAST Data Platform. VAST’s platform delivers the extreme performance, scalability, and simplicity required for demanding AI workloads, while BiocommAI’s BIOTHRIVOLOGY™ provides a technical mechanism for embedding mathematically provable containment and control of advanced AI frontier models with “AI Scientist” goals in the OncoUnity™ cancer services by BiocommAI for the human-aligned benefit of Patients and Doctors, with the infrastructure of the BiocommAI Data Infrastructure equipped with advanced NVIDIA technology supplied by preferred NVIDIA vendor and systems engineer Supermicro.

Key Highlights of the Partnership:

  • Joint Development of Safe AI Data Platforms: BiocommAI and VAST will collaborate to develop integrated solutions that combine the VAST Data Platform with BIOTHRIVOLOGY™ principles, creating a new paradigm for Safe AI infrastructure.
  • Leveraging NVIDIA Ecosystem Synergies: Both companies are deeply integrated with the NVIDIA ecosystem. VAST Data is a Certified Solution Fully Integrated with the NVIDIA Ecosystem, ensuring optimized performance and compatibility. BiocommAI’s membership in NVIDIA Inception further strengthens this alignment, paving the way for streamlined data center infrastructure deployments with NVIDIA.
  • BIOTHRIVOLOGY™ Integration: This partnership will see the implementation of key tenets of BIOTHRIVOLOGY™ within data platform architectures, focusing on provably Safe AI, with transparent and ethical governance of AI systems and healthcare data from the NVIDIA hardware layer upwards, to the OncoUnity™ application layer of Safe AI data delivered by BiocommAI for Patients and Doctors.

Addressing Critical Market Need: The collaboration directly responds to the growing demand for AI solutions that are not only powerful but also demonstrably Safe AI and aligned with human values, addressing concerns around AI risk and responsible and ethical innovation in the AI industry.

“We are thrilled to partner with VAST Data to bring BIOTHRIVOLOGY™ to life on a world-class data platform. VAST’s commitment to performance and scalability, combined with our focus on mathematically provable Safe AI, creates a powerful synergy that will empower our users to engage with advanced AI with confidence and regulatory compliance. We believe this collaboration is crucial in building a future where Safe AI benefits humans, forever.”

Peter A. Jensen, CEO BiocommAI

“VAST Data is committed to providing the foundational infrastructure for the Safe AI era. Partnering with BiocommAI and integrating their innovative BIOTHRIVOLOGY™ framework into our platform is a natural extension of this commitment. Together, we are empowering organizations to not only accelerate their AI initiatives but to do so with a robust focus on safety and ethical requirements. We are excited to engage this partnership and journey toward the future of mathematically provable Safe AI data infrastructure.”

Jeff Denworth, CoFounder at VAST Data

Learn More about:

Visit VAST at NVIDIA GTC 2025: Pavillion 733

About BiocommAI Inc.

BiocommAI is an innovative Safe AI technology company dedicated to designing, engineering, and constructing state-of-the-art data centers specifically optimized for the safe and reliable deployment of Artificial Intelligence for Patients and Doctors. Focused on mathematically provable safety principles, BiocommAI is building the critical infrastructure necessary to unlock the transformative potential of Safe AI for industry and society, while prioritizing ethical requirements to absolutely mitigate existential risks as an example for the AI industry. BiocommAI is committed to leading into the future where the power of Safe AI is harnessed for the benefit of people and society with regulatory compliance and mathematical certainty.

About VAST Data

VAST Data is the data platform company built for the AI era. As the new standard for enterprise AI infrastructure, organizations trust the VAST Data Platform to serve their most data-intensive computing needs. VAST Data empowers enterprises to unlock the full potential of all of their data by providing AI infrastructure that is simple, scalable, and architected from the ground up to power deep learning and GPU-accelerated data centers and clouds. Launched in 2019, VAST Data is the fastest growing data infrastructure company in history.

Contact:

BiocommAI Media Contact
Peter A. Jensen
CEO & Chairman
info@biocomm.ai